Study to Clinically Validate Two Multi-Lead Smartphone-Enabled ECT Devices in an Outpatient Setting


About this study

The purpose of this study is to evaluate the accuracy of wireless multi-lead AliveCor device, in seated and supine position, with traditional ECG and to evaluate the accuracy of the wired multi-lead AliveCor device, in seated and supine position, with traditional EDG.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Male and female patients between the ages of 18-100 years old, already scheduled to have a clinically indicated 12-lead ECG.

  • English speaking.

  • Ability to sit and lie down for an ECG and AliveCor recordings for 30 minutes.

  • Patients who may or may not have a cardiac device implant (pacemaker/ICD).

Exclusion Criteria: 

  • Open chest wounds or recent (<30 days) surgery to the chest or abdomen
  • Absence of any limb that would require modification of lead set-up.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Michael Ackerman, M.D., Ph.D.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer